Cargando…
Serum Proinflammatory Mediators at Different Periods of Therapy in Patients With Multiple Myeloma
Multiple myeloma (MM) is a malignant disease characterized by the clonal proliferation of plasma cells within the bone marrow. Several cytokines have been demonstrated to be involved in the control of growth, progression, and dissemination of MM. We determined serum levels of interleukin-1β (IL-1β),...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526466/ https://www.ncbi.nlm.nih.gov/pubmed/16106104 http://dx.doi.org/10.1155/MI.2005.171 |